🇺🇸 FDA

Drug profile · INN

risankizumab

SKYRIZI

EMA: approved TGA: approved PMDA: approved L04AC18
Patents linked
0
News articles
0

Quick answer

risankizumab (SKYRIZI) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.

Key facts

INN risankizumab
Brand SKYRIZI
ATC code L04AC18
Originator AbbVie

Frequently asked questions

What is risankizumab?

risankizumab (SKYRIZI) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.

What is the brand name for risankizumab?

SKYRIZI is a marketed brand name for risankizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.